Improving outcomes in SLE
Improving outcomes in SLE
改善 SLE 的治疗结果
批准号：
nhmrc : 1196218
负责人：
金额：
$142.5万
依托单位国家：
澳大利亚
项目类别：
Investigator Grants
财政年份：
2021
资助国家：
澳大利亚
项目状态：
未结题
起止时间：
2021-01-01 至 2025-12-31
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
There has been no significant breakthrough in the treatment of Systemic Lupus Erythematosus (SLE) for over 50 years. Treatment continues to rely on non-specific immunosuppressant drugs and glucocorticoids (GC, or ‘steroids’), and the impact on patients includes high mortality and poor quality of life. In this proposal, I will validate novel endpoints which will break the impasse in SLE drug development and develop tools for minimising GC use in SLE.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
